Champions Oncology Inc. (CSBR) Stock Price, Quote & News

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Champions Oncology Inc. (CSBR)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

9.45

0.28 (3.05%)

At close: Jan 14, 2025, 3:59 PM

9.67

2.33%

After-hours Jan 14, 2025, 04:00 PM EST

undefined% (undefined)

Bid	9.11
Market Cap	130.59M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-0.05
PE Ratio (ttm)	-189
Forward PE	n/a
Analyst	Strong Buy

Ask	10.52
Volume	29,983
Avg. Volume (20D)	43,268
Open	9.18
Previous Close	9.17
Day's Range	9.13 - 9.67
52-Week Range	3.60 - 10.90
Beta	undefined

About CSBR

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune...

[Show more]

Industry Biotechnology

Sector Healthcare

IPO Date Feb 2, 2007

Employees 210

Stock Exchange NASDAQ

Ticker Symbol CSBR

Website https://www.championsoncology.com

Analyst Forecast

According to 1 analyst ratings, the average rating for CSBR stock is "Strong Buy." The 12-month stock price forecast is $8, which is a decrease of -15.34% from the latest price.

Buy 100.00%

Hold 0.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

Champions Oncology Inc. is scheduled to release its earnings on Mar 11, 2025, during market hours.
Analysts project revenue of $12.93M, reflecting a 7.58% YoY growth and earnings per share of -0.01, making a -93.75% decrease YoY.

Why Price Moved

1 month ago · Source

+12.09%

Champions Oncology shares are trading higher after... Unlock content with Pro Subscription

4 months ago · Source

+9.58%

Champions Oncology shares are trading higher after the company reported better-than-expected Q1 financial results. Also, Craig-Hallum upgraded the stock from Hold to Buy and maintained its $6 price target.

News

2 weeks ago · seekingalpha.com

Champions Oncology: Right Point To Own In The Cycle Thanks To Operating Efficiencies

Champoins Oncology broke out of a multiyear downtrend following its Q2'25 earnings. Management has embarked on a one-way journey to reduce working capital and grow the business with zero incremental c...

1 month ago · seekingalpha.com

Champions Oncology, Inc. (CSBR) Q2 2025 Earnings Call Transcript

Champions Oncology, Inc. (NASDAQ:CSBR ) Q3 2024 Earnings Conference Call December 11, 2024 4:30 PM ET Company Participants Ronnie Morris - Chief Executive Officer David Miller - Chief Financial Office...